http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Twist Bioscience Enters into Third Collaboration with Astellas to Support Antibody Discovery for Immunotherapies
-
Twist Bioscience Corporation (TWST) Launches TCR and CAR Libraries
-
Twist Bioscience Launches TCR and CAR Libraries to Enable the Development of Cell Therapies
-
Twist Bioscience to Report Fiscal 2023 Second Quarter Financial Results on Friday, May 5, 2023
-
DNA Data Storage Alliance Announces Board Appointments
-
Twist Bioscience (TWST) Announces Robust Antibody Discovery Services Integrating In Vivo, In Vitro and In Silico Approaches
-
Twist Bioscience Announces Robust Antibody Discovery Services Integrating In Vivo, In Vitro and In Silico Approaches
-
Twist Bioscience to Present at Upcoming Investor Conferences
-
Twist Bioscience Publishes Data on VHH Single Domain Antibody Discovery Using New Methodology on Optofluidic Platform
-
TWST FINAL DEADLINE FRIDAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action – TWS
-
Twist Bioscience Announces Technology Early Access of Enhanced Whole Genome Sequencing Solution at AGBT
-
Twist Bioscience Reports Fiscal First Quarter 2023 Financial Results
-
Twist Bioscience Begins Shipping Commercial Product from Synthetic DNA Manufacturing Factory of the Future
-
Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023
-
Twist Bioscience and CENTOGENE Launch Three Panels to Advance Rare Disease and Hereditary Cancer Research and Support Diagnostics
-
Twist Bioscience and Astellas Enter into Multitarget Antibody Discovery Research Collaboration
-
Twist Bioscience to Present at the 41st Annual J.P. Morgan Health Care Conference
-
Twist Bioscience to Present at 5th Annual Evercore ISI HealthCONx Conference
-
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2022 Financial Results
-
Twist Bioscience Corporation (TWST) Responds to Short-Seller Report
-
Twist Bioscience Addresses Misleading Short-Seller Report
-
Twist Bioscience to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results on Friday, November 18, 2022
-
Twist Bioscience to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results on Friday, November 18, 2022
-
Twist Bioscience Corporation (TWST) and Illumina (ILMN) Partner to Produce Robust Exome Panel to Advance Research
-
Twist Bioscience and Illumina Partner to Produce Robust Exome Panel to Advance Research
-
Twist Bioscience Corporation (TWST) Appoints Patrick Finn as President and COO
-
Twist Bioscience Promotes Patrick Finn, Ph.D., to President and Chief Operating Officer
-
Twist Bioscience Launches Human Sample ID Kit to Track Whole Blood Samples Through Lab Testing Workflow
-
Twist Bioscience Earns 2022 Great Place to Work Certification
-
Twist Bioscience to Present at JSNN NanoImpacts 2022
-
The Australian Research Council Centre of Excellence in Synthetic Biology and Twist Bioscience Partner to Foster and Accelerate Synthetic Biology Research in Australia
-
Twist Bioscience to Present at Baird 2022 Global Healthcare Conference
-
Twist Bioscience Reports Fiscal Third Quarter 2022 Financial Results
-
Twist Bioscience to Present at Flash Memory Summit
-
Twist Bioscience Corporation (TWST) and Biotia Receive Expanded EMA to Report Genetic Variants of SARS-CoV-2
-
Twist Bioscience Highlights White Paper Sizing Future DNA Data Storage Market
-
Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants of SARS-CoV-2
-
Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
-
Twist Bioscience to Report Fiscal 2022 Third Quarter Financial Results on Friday, August 5, 2022
-
Twist Bioscience Corporation (TWST) Launches Monkeypox Virus Synthetic DNA Controls
-
Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls
-
Twist Bioscience (TWST) and DNAnexus Collaborate to Provide Data Analysis Software for NGS Workflow
-
DNAnexus and Twist Bioscience Collaborate to Provide Data Analysis Software for NGS Workflow
-
Twist Bioscience Corporation (TWST) Opens New Twist Boston Location to Expand Antibody Discovery Capacity
-
Twist Bioscience Opens New Twist Boston Location to Expand Antibody Discovery Capacity
-
Twist Bioscience (TWST) and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology
-
Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology
-
Twist Bioscience to Present at Fujifilm’s 12th Annual Global IT Executive Summit
-
Twist Bioscience Corporation (TWST) Launches Twist MRD Rapid 500 Panel1
-
Twist Bioscience Launches Rapid Turnaround, Customizable Panels to Advance R&D in Minimal Residual Disease (MRD) Detection in Cancer Screening

